New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
2h
News-Medical.Net on MSNFGFR2 identified as key driver in KRAS-mutated pancreatic cancer progressionPrecancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...
In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...
Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...
Pancreatic Cancer UK is the TCS London Marathon’s charity of the year and is aiming to raise £2 million for a breath test to ...
Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ...
The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...
Tim Mohr, the acclaimed journalist, author, and translator who collaborated on memoirs with Guns N’ Roses’ Duff McKagan and ...
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...
NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...
On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results